Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER) von Matza, Louis S., Boye, Kristina S., Stewart, Katie D., Coyne, Karin S., Wullenweber, Paula K., Cutts, Katelyn N., Jordan, Jessica B., Wang, Qianqian, Yu, Maria, Currie, Brooke M., Malley, Karen G., Ishak, K. Jack, Hietpas, Ryan T., García‐Pérez, Luis‐Emilio

Volltext

Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes von Kazda, Christof M, Bue-Valleskey, Juliana M, Chien, Jenny, Zhang, Qianyi, Chigutsa, Emmanuel, Landschulz, William, Wullenweber, Paula, Haupt, Axel, Dahl, Dominik

Volltext

Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study von Frias, Juan, Chien, Jenny, Zhang, Qianyi, Chigutsa, Emmanuel, Landschulz, William, Syring, Kristen, Wullenweber, Paula, Haupt, Axel, Kazda, Christof

Volltext

192-OR: Glycemic Control with Once-Weekly Basal Insulin Fc (BIF) in Persons with Type 2 Diabetes Mellitus (T2DM) Using Continuous Glucose Monitoring (CGM) in a Phase 2 Study von KAZDA, CHRISTOF M., CHIEN, JENNY, ZHANG, QIANYI, CHIGUTSA, EMMANUEL, LANDSCHULZ, WILLIAM, WULLENWEBER, PAULA, HAUPT, AXEL, FRIAS, JUAN P.

Volltext

Cover Image, Volume 22, Issue 3 von Matza, Louis S., Boye, Kristina S., Stewart, Katie D., Coyne, Karin S., Wullenweber, Paula K., Cutts, Katelyn N., Jordan, Jessica B., Wang, Qianqian, Yu, Maria, Currie, Brooke M., Malley, Karen G., Ishak, K. Jack, Hietpas, Ryan T., García‐Pérez, Luis‐Emilio

Volltext

Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious in Patients with Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin von Frias, Juan Pablo, Chien, Jenny, Zhang, Qianyi, Chigutsa, Emmanuel, Landschulz, William, Wullenweber, Paula, Haupt, Axel, Kazda, Christof

Volltext